Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of a global pandemic. Safe and effective COVID-19 vaccines are now available, including mRNA-1273, which has shown 94% efficacy in prevention of symptomatic COVID-19 disease. However, the emergence of SARS-CoV-2 vari...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:bioRxiv
Main Authors: Wu, Kai, Choi, Angela, Koch, Matthew, Elbashir, Sayda, Ma, LingZhi, Lee, Diana, Woods, Angela, Henry, Carole, Palandjian, Charis, Hill, Anna, Jani, Hardik, Quinones, Julian, Nunna, Naveen, O’Connell, Sarah, McDermott, Adrian B, Falcone, Samantha, Narayanan, Elisabeth, Colpitts, Tonya, Bennett, Hamilton, Corbett, Kizzmekia S, Seder, Robert, Graham, Barney S, Stewart-Jones, Guillaume BE, Carfi, Andrea, Edwards, Darin K
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8057233/
https://ncbi.nlm.nih.gov/pubmed/33880468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.04.13.439482
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados